FDA Inspection
LifeStream Blood BankLifeStream Blood Bank – FDA Inspection, Feb 13, 2012
Record Details
This FDA Inspection record concerns LifeStream Blood Bank, with an inspection on February 13, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- LifeStream Blood Bank
- Inspection Date
- February 13, 2012
- Product Type
- Biologics
View Company Profile
ID · 868e7d3c-e987-4455-8ee5-ef32a623528a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 766903
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 640.3(c)(2)History of viral hepatitis - close contact
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeStream Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 9, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 4, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeStream Blood Bank
- FDA Inspection 1181591 - 2022-10-11
- FDA Inspection 1064697 - 2018-08-23
- FDA Inspection 964887 - 2016-03-09
- FDA Inspection 853960 - 2013-11-04
- FDA Inspection 700767 - 2010-12-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.